Clarity Senior Executive Changes – Dr Colin Biggin to Acting Chief Executive Officer, Dr Matt Harris to Chief Scientific Officer
Sydney, Australia 3 April 2019 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce changes to its senior executive team to help its focus on commercial development and execution of its pipeline of radiopharmaceutical products for the treatment of children and adults with cancer. Dr Matt Harris,…